Ledger.Open graph →
SEC Form D · filed June 17, 2014

K2 THERAPEUTICS, INC

Offering
$42.7M
Sold
$30.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Dan Burgess · San Diego, CADirectorKevin Judice · San Diego, CAExec · DirectorScott Rocklage · San Diego, CADirectorTed Schroeder · San Diego, CADirectorJeffrey Stein · San Diego, CAExec · DirectorKevin Forrest · San Diego, CAExecPatrick Heron · San Diego, CADirectorSteve Elms · San Diego, CADirectorNina Kjellson · San Diego, CADirectorDavid Dewhurst · Houston, TXExec · DirectorGene Dewhurst · Houston, TXExecJohn B. Oxaal · Charlotte, NCDirectorMichael Gutschmit · Charlotte, NCDirectorMark Horinko · Charlotte, NCDirectorSean Cantwell · Ottawa, Ontario, CanadaExec · DirectorAndrew Waitman · Ottawa, Ontario, CanadaDirectorMatt Whitteker · Ottawa, Ontario, CanadaDirectorJonathan Hughes · Ottawa, Ontario, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗